Transferable Exclusivity Voucher for priority antimicrobials under the EU Pharma Law Package – What can innovators do now?
USMCA Joint Review could establish Rapid Response Environment Mechanism to address environmental violations
CMS issues first proposed rule for the IRA’s Drug Price Negotiation Program, for IPAY 2029 and beyond